A Phase 1 Dose-Escalation Study Of Anti-Her3 Monoclonal Antibody Ljm716 In Combination With Trastuzumab In Patients With Her2-Overexpressing Metastatic Breast Or Gastric Cancer
JOURNAL OF CLINICAL ONCOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要